Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, August 11, 2022
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
Wed, August 10, 2022
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
Vikram Purohit Maintained (AXSM) at Hold with Increased Target to $55 on, Aug 10th, 2022
Vikram Purohit of Morgan Stanley, Maintained "Axsome Therapeutics, Inc." (AXSM) at Hold with Increased Target from $54 to $55 on, Aug 10th, 2022.
Vikram has made no other calls on AXSM in the last 4 months.
There are 3 other peers that have a rating on AXSM. Out of the 3 peers that are also analyzing AXSM, 0 agree with Vikram's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Vikram
- Charles Duncan of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $64 on, Wednesday, June 29th, 2022
- Joseph Thome of "Cowen & Co." Maintained at Buy with Increased Target to $130 on, Wednesday, June 29th, 2022
- Vamil Divan of "Mizuho" Maintained at Strong Buy with Decreased Target to $49 on, Tuesday, May 3rd, 2022
